Expert Interviews: Closing Gaps in HCV Care
Gaps in care for patients with hepatitis C infection and possible interventions were explored in interviews with several doctors.
Viral Hepatitis
Guideline Updated for Prevention, Management of Hep C in CKD
In a clinical practice guideline, updated recommendations are presented for the prevention, diagnosis, treatment, and management of hepatitis C virus (HCV) infection in adults with chronic kidney disease.
Glecaprevir/Pibrentasvir Efficacious for HCV in Highly Endemic Areas
Researchers found data from that showed the once-daily, direct-acting antiviral regimen, glecaprevir co-formulated with pibrentasvir, is effective and safe in hepatitis C.
HEV Infections Among HIV-Positive Individuals During an Outbreak of Hepatitis A
Researchers found data that showed among patients who are HIV positive, hepatitis E viral transmission is unrelated to sexually transmitted disease.
An Optimized Cell Culture System Needed for Hepatitis E Virus Subtypes
After expanding, freezing, thawing and re-culturing novel wild-type isolates of hepatitis E, investigators in Europe observed what they categorized as an unlimited production of hepatitis E virus during a period of 2 years, which they believe will allow in vitro testing for the effectiveness of sofosbuvir in combination with ribavirin or silvestrol.
Eight-Week Pan-Genotypic Treatment Option Approved for HCV Patients With Compensated Cirrhosis
The FDA has expanded the approval of Mavyret, shortening the treatment duration from 12 weeks to 8 weeks in treatment-naïve adults and children 12 years of age and older with chronic hepatitis C and compensated cirrhosis across all HCV genotypes.
Alternative Hepatitis Testing Tools Facilitate WHO’s Goal of Hepatitis Elimination
Researchers found data that showed initiatives to test for hepatitis are vital to decrease infections because many patients remain asymptomatic for years, which is when chronic infection leads to complications.
HDV Persists During Liver Regeneration and is Amplified Through Cell Division
Researchers found that hepatitis delta virus endures cell division in vitro and in vivo, which they believe shows a need for the development of antiviral agents that target hepatitis delta virus and reinfection of human hepatocytes.
Statins Linked to Lower Risk of Liver Cancer in Patients With Hepatitis B/C
Lipophilic statins were linked to a lower risk of hepatocellular carcinoma and death in a cohort of patients with chronic hepatitis B/C.
1971 to 2017 Saw 32 Drinking Water Hepatitis A Outbreaks
Thirty-two outbreaks of hepatitis A associated with drinking water were identified during 1971 to 2017, and all occurred before 2010.
Next post in Liver
